Jeong-Woo Kang
Overview
Explore the profile of Jeong-Woo Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Lee S, Jo S, Cho K, Park J, Kwon J, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358221
Recently, there has been an increasing number of blight disease reports associated with and in South Korea. Current management protocols that have been conducted with antibiotics have faced resistance problems...
2.
Kim S, Giri S, Jo S, Kang J, Lee S, Jung W, et al.
Antibiotics (Basel)
. 2022 Sep;
11(9).
PMID: 36140043
With concern growing over antibiotics resistance, the use of bacteriophages to combat resistant bacteria has been suggested as an alternative strategy with which to enable the selective control of targeted...
3.
Kim M, Kang J, Jeon J, Kim J, Kim J, Hong J, et al.
Oncotarget
. 2015 Oct;
6(38):40747-61.
PMID: 26516703
The proinflammatory cytokine TNF-α is highly expressed in patients with acute myeloid leukemia (AML) and has been demonstrated to induce rapid proliferation of leukemic blasts. Thus suppressing the production of...
4.
Kim M, Kang J, Park Y, Lee D, Bak Y, Kwon T, et al.
Oncotarget
. 2015 Mar;
6(6):4394-405.
PMID: 25726525
PU.1 is a key transcription factor regulating the myeloid differentiation. PU.1-induced monocytic differentiation into macrophage is also important for blood cancer development. Therefore, we chose THP-1 monocytic leukemia cells to...
5.
Bak Y, Kang J, Kim M, Park Y, Kwon T, Kim S, et al.
Cell Signal
. 2014 Oct;
26(12):3007-15.
PMID: 25280942
Interleukin-32 (IL-32) exists in several isoforms and plays an important role in inflammatory response. Recently, we identified a new isoform, IL-32θ, and performed a microarray analysis to identify IL-32θ-regulated genes...
6.
Park Y, Kang J, Lee D, Kim M, Bak Y, Yang Y, et al.
Oncotarget
. 2014 Sep;
5(18):8765-77.
PMID: 25245533
A proinflammatory cytokine IL-32 acts as an intracellular mediator. IL-32α interacts with many intracellular molecules, but there are no reports of interaction with a transcriptional repressor BCL6. In this study,...
7.
Park Y, Kang J, Lee D, Kim M, Bak Y, Yang Y, et al.
Int J Biochem Cell Biol
. 2014 Sep;
55:136-43.
PMID: 25178676
Interleukin-32 (IL-32) is a proinflammatory cytokine. However, there is growing evidence that IL-32 also plays a mediatory role intracellularly. In this study, we present evidence that IL-32α modifies and inhibits...
8.
Kim M, Kang J, Lee D, Bak Y, Park Y, Song Y, et al.
FEBS Lett
. 2014 Jul;
588(17):2822-9.
PMID: 24996056
It has been well known that IL-32 exerts pro-inflammatory effects on the various inflammatory diseases in clinical studies. Here, we confirmed that IL-32θ, a new isoform of IL-32, decreased the...
9.
Kang J, Park Y, Kim M, Lee D, Bak Y, Ham S, et al.
Cell Signal
. 2014 Apr;
26(7):1514-22.
PMID: 24703937
Myeloid-specific CD18 associates with CD11 and plays a critical role in leukocyte adhesion to the endothelium. In this study, we observed that CD18 expression was decreased by IL-32α in THP-1...
10.
Kang J, Park Y, Lee D, Kim M, Bak Y, Park S, et al.
FEBS Lett
. 2014 Feb;
PMID: 24512848
There is growing evidence for multifunctional properties of IL-32. We previously demonstrated that IL-32β upregulates IL-10 production through the association with PKCδ. In this study, we examined the effects of...